Michael Jeffers

Title: Michael Jeffers: Innovator in Cancer Treatment

Introduction

Michael Jeffers is an accomplished inventor based in Ridgewood, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer. His work has led to the creation of a patent that showcases his expertise and dedication to improving patient outcomes.

Latest Patents

Michael Jeffers holds a patent for "Substituted 2,3-dihydroimidazo[1,2-C]quinazoline-containing combinations." This invention relates to combinations of specific compounds that can be used in the preparation of a medicament for the treatment or prophylaxis of cancer. The patent outlines various components, including 2,3-dihydroimidazo[1,2-c]quinazoline compounds and substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]-triazin-4-amine compounds. The invention also discusses the use of biomarkers for predicting patient sensitivity to treatment and methods for determining genetic perturbations associated with cancer.

Career Highlights

Throughout his career, Michael Jeffers has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma and Bayer Healthcare Pharmaceuticals. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in cancer treatment.

Collaborations

Michael has collaborated with notable colleagues such as Isabelle Genvresse and Carol Pena. These partnerships have enriched his work and fostered an environment of innovation and discovery.

Conclusion

Michael Jeffers is a notable inventor whose work in cancer treatment exemplifies the impact of innovative thinking in pharmaceuticals. His patent and career achievements reflect his commitment to advancing medical science and improving patient care.